| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Oyster Point Pharma, Inc. | Chief Commercial Officer | Common Stock | 30.3K | $340K | $11.20 | Jan 9, 2022 | Direct |
| ALIMERA SCIENCES INC | Director | Common Stock | 0 | $0 | $3.83 | Sep 16, 2024 | Direct |
| Oyster Point Pharma, Inc. | Chief Commercial Officer | Employee Stock Option (Right to Buy) | 54.5K | Jan 9, 2022 | Direct | ||
| ALIMERA SCIENCES INC | Director | Stock Option (Right to Buy) | 0 | Sep 16, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ALIM | ALIMERA SCIENCES INC | Sep 16, 2024 | 6 | $0 | 4 | Sep 18, 2024 | Director |
| ALIM | ALIMERA SCIENCES INC | Oct 2, 2023 | 1 | $0 | 4 | Oct 4, 2023 | Director |
| ALIM | ALIMERA SCIENCES INC | Jan 4, 2023 | 1 | $0 | 4 | Jan 6, 2023 | Director |
| OYST | Oyster Point Pharma, Inc. | Jan 9, 2022 | 2 | $0 | 4 | Jan 11, 2022 | Chief Commercial Officer |
| ALIM | ALIMERA SCIENCES INC | Nov 2, 2021 | 1 | $0 | 4 | Nov 4, 2021 | Director |
| OYST | Oyster Point Pharma, Inc. | Sep 22, 2021 | 1 | $0 | 4 | Sep 24, 2021 | Chief Commercial Officer |